查詢結果分析
相關文獻
- Drug Utilization among Elders with Parkinson's Disease in Taiwan: A Nationwide Study in 2004
- Spinal Fusion and Pedicle Screw Instrumentation in the Treatment of Spondylolisthesis Over the Age of 60
- Surgical Treatment of Intracranial Meningiomas in Geriatric Patients
- Analysis of Referral Source, Severity, and Return Among the Elderly in Rural Primary Care
- 中老年人之運動保健
- 回憶療法於老年護理之運用
- 老年病人的急性混亂
- Orem理論應用--一位燙傷老人的護理經驗
- An Analysis of Referral Initiative, Severity, and the Return of Older Population in a Tertiary Teaching Hospital
- 孫思邈養性、養生與老年醫學擷要
頁籤選單縮合
題 名 | Drug Utilization among Elders with Parkinson's Disease in Taiwan: A Nationwide Study in 2004=臺灣老年帕金森氏症患者藥物使用之全國性研究 |
---|---|
作 者 | 謝宛婷; 王芳綺; 蔡岡廷; 黃建程; 陳曾基; 黃信彰; 蘇世斌; 陳炳仁; | 書刊名 | 臺灣老年醫學暨老年學雜誌 |
卷 期 | 9:3 2014.08[民103.08] |
頁 次 | 頁111-126 |
分類號 | 418.2251 |
關鍵詞 | 老年; 抗帕金森氏症藥物; 帕金森氏症; 藥物利用; 國家健康保險; Aged; Antiparkinson agents; Drug utilization; National health programs; Parkinson's disease; |
語 文 | 英文(English) |
中文摘要 | 目的:在台灣因帕金森氏症(Parkinson's disease, PD)接受抗帕金森氏症藥物(Anti-parkinsonian drug, APD)治療的老年病患之用藥內容過去極少被檢視分析,本研究將針對全台灣使用抗帕金森氏症藥物治療的老年患者分析其醫師處方以及因其他非動作障礙疾患使用藥物之現況。方法:本研究中PD為國際疾病分類系統(ICD-9-CM)診斷碼332.0,APD則取自ATC(Anatomical Therapeutic Chemical)藥品分類系統N04組的藥物。由2004年全民健康保險研究資料庫中60歲以上老年族群之門診處方中篩選出使用APD的患者,並分析該年度最後一張處方上其他合併用藥的內容,包含抗憂鬱用藥、抗精神病藥物、安眠藥、助排便藥與泌尿系統藥物的開立狀況,並比較與其他未使用APD藥物患者處方的差異。結果:在2004年共有24,934位老年PD患者開立有APD的處方服用。其中值得注意的是抗乙烯膽鹼藥物與麥角鹼衍生物多巴胺促效劑被使用的頻率甚高(各佔33.1%和9.5%)。相較於其他非PD的老年人,PD患者常同時合併使用非動作障礙藥物,其使用頻率比例如下:泌尿系統藥物(1.71倍)、助排便藥物(1.87倍)、安眠鎮靜藥物(2.21倍)、抗精神病藥物(2.80倍)以及抗憂鬱藥物(3.04倍)。結論:台灣老年PD患者較常使用的抗乙烯膽鹼藥物與多巴胺促效劑,所引發的病患安全性值得我們去關注並需要更多的研究。與其他非PD患者的老年人相較,PD患者需要臨床醫師更仔細的去察覺非動作障礙的症狀,以符合其較複雜的照護需求。如能建立台灣PD老年患者的用藥指引,將更能提升這群病患的照護品質。 |
英文摘要 | Background: Drug utilization in elderly patients with Parkinson's disease (PD) in Taiwan has rarely been studied. This study investigated the potentially questionable prescribing patterns of antiparkinsonian drugs (APDs) and concomitant medication in elderly PD patients in Taiwan. Methods: Participants aged 60 and older, diagnosed with PD, and prescribed dopaminergic agents in 2004 were selected from Taiwan's National Health Insurance Research Database. For each patient, prescriptions containing APDs during the previous one year was analyzed to identify the prescribing pattern. The frequency of using antidepressants, antipsychotics, hypnotics and sedatives, propulsives and laxatives, and urologicals was compared between the elderly PD patients and other non-PD patients during a 12-month period. Results: A total of 24,934 elderly PD patients were prescribed APDs in 2004. The frequent use of anticholinergic agents and ergot-derived DAs in Taiwan was noteworthy (33.1% and 9.5% of PD patients, respectively). Elderly PD patients were more likely to receive pharmacotherapies for non-motor symptoms than their non-PD counterparts as indicated by the following rate ratios: 1.71 (urologicals), 1.87 (propulsives and laxatives), 2.21 (hypnotics and sedatives), 2.80 (antipsychotics), and 3.04 (antidepressants). Conclusions: The frequent use of anticholinergic agents and ergot-derived DAs in senior PD patients in Taiwan raises concerns about patient safety and merits further studies. The more complex care needs of senior PD patients for non-motor manifestations require careful physician attention in clinical practice. Introducing practice guidelines for the pharmacotherapy of PD in Taiwan is necessary for promoting the quality of PD care in its elderly population. |
本系統中英文摘要資訊取自各篇刊載內容。